DiaSorin S.p.A. (BIT:DIA)
Italy · Delayed Price · Currency is EUR 69.74
-1.22 (-1.72%)
At close: Mar 3, 2026
DiaSorin Revenue
DiaSorin had revenue of 280.00M EUR in the quarter ending September 30, 2025, a decrease of -2.44%. This brings the company's revenue in the last twelve months to 1.21B, up 2.65% year-over-year. In the year 2024, DiaSorin had annual revenue of 1.19B with 3.24% growth.
Revenue (ttm)
1.21B
Revenue Growth
+2.65%
P/S Ratio
3.11
Revenue / Employee
373.05K
Employees
3,280
Market Cap
3.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 37.22M | 3.24% |
| Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
| Dec 31, 2022 | 1.36B | 123.48M | 9.98% |
| Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
| Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| Amplifon | 2.41B |
| Safilo Group | 998.89M |
| EL.En. | 580.41M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 483.61M |
| Svas Biosana | 134.95M |
| Talea Group | 132.17M |
DiaSorin News
- 4 months ago - Invesco International Small-Mid Company Fund Q3 2025 Portfolio Positioning - Seeking Alpha
- 10 months ago - DiaSorin: Anticipate A Double-Digit EBITDA Growth Rate - Seeking Alpha
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Italy's DiaSorin ex-Covid revenue in line with guidance - Reuters
- 1 year ago - Diagnostics group DiaSorin's nine-month adjusted core profit up 6% - Reuters
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 years ago - DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Diasorin 2023 revenue drops 14%, in line with guidance; shares fall - Reuters